United States · FDA National Drug Code directory
RASAGILINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-446_fa1b2a7e-f459-4432-97f2-23d2c07c2dac
- Product NDC
- 13668-446
- Form
- TABLET
- Composition / generic term
- RASAGILINE
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251115
- Source listing expiry
- 20271231
Source-listed ingredients
- RASAGILINE MESYLATE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 CONTAINER (13668-446-05) · 13668-446-05
- 30 TABLET in 1 CONTAINER (13668-446-30) · 13668-446-30
- 90 TABLET in 1 CONTAINER (13668-446-90) · 13668-446-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →